Jose Pablo Leone, MD, provides an overview of a study of PI3K inhibitor GDC-0084 with trastuzumab in patients with HER2-positive breast cancer that has metastasized to the brain.
Dana-Farber Cancer Institute offers the largest number of clinical trials for metastatic breast cancer in the country through our Embrace program. For more information about clinical trials for breast cancer, please visit [ Ссылка ].
For more information about Embrace, please visit [ Ссылка ]
